Bausch Health Companies Inc. Common Stock (BHC)

R&D Expenses

$173.00M

Quarterly · Period ending: · USD

BHC logo

BHC R&D Expenses

Latest reported$173.00M
BHC Quarterly R&D Expenses ($0.00 → $173.00M)
High-resolution chart · PNG

BHC r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bausch Health Companies Inc. Common Stock R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
173,000,000
163,000,000
51,000,000
247,000,000
159,000,000
143,000,000
163,000,000
161,000,000
159,000,000
151,000,000
152,000,000
153,000,000
156,000,000
143,000,000
142,000,000
133,000,000
128,000,000
127,000,000
122,000,000
121,000,000
116,000,000
114,000,000
132,000,000
115,000,000
115,000,000
123,000,000
150,000,000
124,000,000
124,000,000
118,000,000
121,000,000
107,000,000
94,000,000
93,000,000
90,000,000
81,000,000
95,000,000
100,000,000
93,000,000
132,000,000
126,000,000
104,000,000
201,500,000
101,600,000
81,100,000
55,800,000
59,100,000
59,100,000
74,900,000
73,300,000
54,900,000
173,000,000
24,500,000
23,800,000
20,165,000
164,470,000
22,279,000
22,006,000
121,977,000
17,476,000
17,764,000
15,670,000
39,113,000
14,298,000
37,258,000
66,887,000
38,362,000
23,202,000
44,692,000
14,528,000
16,085,000
18,668,000
21,759,000
36,332,000
29,274,000
30,674,000
28,447,000
29,722,000
28,394,000
26,350,000
18,402,000
22,328,000
26,749,000
19,913,000
22,752,000
20,487,000
21,031,000
17,648,000
15,830,000
17,991,000
26,143,000
20,608,000
21,813,000
18,006,000
12,603,000
14,626,000
14,453,000
10,468,000
14,154,000
12,018,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.